Nevus Senescence. (22nd June 2011)

• Record Type: Journal Article
• Authors: Ross, Andrew L.; Sanchez, Margaret I.; Grichnik, James M.
• Other Names: Alaibac M. Academic Editor.; Chao S.-C. Academic Editor.; Darwiche N. Academic Editor.
• Is Part Of: ISRN dermatology. Volume 2011(2011)
• Publication Date: 2011-06-22
• Subjects: Dermatology -- Periodicals; Skin Diseases; Dermatology; Dermatology; Periodicals; 616.5
• DOI: 10.5402/2011/642157
• Languages: English
• ISSNs: 2090-4592

Abstract

Abstract : Melanomas and nevi share many of the same growth-promoting mutations. However, melanomas grow relentlessly while benign nevi eventually undergo growth arrest and stabilize. The difference in their long-term growth potential may be attributed to activation of cellular senescence pathways. The primary mediator of senescence in nevi appears to be p16. Redundant, secondary senescence systems are also present and include the p14-p53-p21 pathway, the IGFBP7 pathway, the FBXO31 pathway, and the PI3K mediated stress induced endoplasmic reticulum unfolded protein response. It is evident that these senescence pathways result in an irreversible arrest in most instances; however, they can clearly be overcome in melanoma. Circumvention of these pathways is most frequently associated with gene deletion or transcriptional repression. Reactivation of senescence mechanisms could serve to inhibit melanoma tumor progression.